Table 4.
Category | Variable | Estimate | SE | Wald chi-square | P-value |
---|---|---|---|---|---|
Items 1~3 symptoms | Intercept | 4.033 | 0.477 | 71.431 | <0.001 |
Experimental groupa | 0.567 | 0.730 | 0.602 | 0.438 | |
T2b | 0.497 | 0.530 | 0.879 | 0.348 | |
T1b | 1.039 | 0.536 | 3.755 | 0.053 | |
Experimental group* T2c | −1.794 | 0.7626 | 5.535 | 0.019* | |
Experimental group* T1c | −1.855 | 0.7215 | 6.606 | 0.010* | |
Items 4~6 activity | Intercept | 1.733 | 0.3494 | 24.612 | <0.001 |
Experimental groupa | 0.767 | 0.6086 | 1.587 | 0.208 | |
T2b | 0.028 | 0.4432 | 0.004 | 0.95 | |
T1b | 0.738 | 0.4305 | 2.939 | 0.086 | |
Experimental group* T2c | −0.979 | 0.7575 | 1.671 | 0.196 | |
Experimental group* T1c | −1.763 | 0.7384 | 5.704 | 0.017* | |
Items 7~8 impact | Intercept | 2.833 | 0.4057 | 48.763 | <0.001 |
Experimental groupa | 0.000 | 0.6415 | 0.000 | 1.000 | |
T2b | −0.406 | 0.5587 | 0.529 | 0.467 | |
T1b | 0.693 | 0.4417 | 2.465 | 0.116 | |
Experimental group* T2c | 0.507 | 0.6465 | 0.614 | 0.433 | |
Experimental group* T1c | −0.371 | 0.5580 | 0.442 | 0.506 |
Notes: *P<0.05. aReference group: control group, breference group: T0 (baseline), creference group: control group *T0 (T0=baseline, T1=1 month after intervention, T2=3 months after intervention).